This is an unprecedented time. It is the dedication of healthcare workers that will lead us through this crisis. Thank you for everything you do.
COVID-19 Resource Center

      Calc Function

    • Calcs that help predict probability of a diseaseDiagnosis
    • Subcategory of 'Diagnosis' designed to be very sensitiveRule Out
    • Disease is diagnosed: prognosticate to guide treatmentPrognosis
    • Numerical inputs and outputsFormula
    • Med treatment and moreTreatment
    • Suggested protocolsAlgorithm

    Disease

    Select...

    Specialty

    Select...

    Chief Complaint

    Select...

    Organ System

    Select...

    Patent Pending

    Log In

    Show
    Forgot your password?
    Log In
    Or create a new account (it's free)

    Forgot Password?

    Enter your email address and we'll send you a link to reset your password.

    Get New Password

    Sign In Required

    To save favorites, you must log in.

    Creating an account is free, easy, and takes about 60 seconds.

    Attention COACH STUDY participants:

    The principal investigators of the study request that you use the official version of the modified score here.

    Maternal-Fetal Hemorrhage Rh(D) Immune Globulin Dosage

    Calculates amount of RhIG to be administered to the mother, at the time of delivery, to prevent hemolytic disease of the fetus and newborn (HDFN).
    Favorite

    IMPORTANT

    This dosing tool is intended to assist with calculation, not to provide comprehensive or definitive drug information. Always double-check dosing of any drug and consult a clinical pathologist or pharmacist when necessary.

    When to Use
    Pearls/Pitfalls
    Why Use

    This calculator should be used to compute the number of RhIG vials to administer to an Rh-negative mother who has not yet developed an anti-D, when she gives birth to an Rh-positive child.

    • Calculation of maternal blood volume is an estimation using Nadler’s equation.
    • Fetal cell percentage can be obtained by both flow cytometry or Kleihauer-Betke methodology.

    When a mother who is Rh-negative gives birth to a baby who is Rh-positive, there is a possibility that the mother could develop an antibody to the D antigen due to mixing of fetal and maternal blood. The presence of an anti-D leads to a potential risk for HDFN in future pregnancies. Therefore, to prevent HDFN and the formation of an anti-D in the mother, RhIG is given to the mother at 28 weeks and after birth. The amount of RhIG given to the mother after birth is dependent on the amount of fetal-maternal hemorrhage. This formula calculates the amount of fetal-maternal hemorrhage as well as the number of RhIG vials be given to the mother.

    mL
    %

    Result:

    Please fill out required fields.

    Next Steps
    Evidence

    Advice

    RhIG should be given to the mother at 28 weeks and after birth.

    Content Contributors
    Content Contributors